• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇通过抑制极光激酶介导的丝切蛋白-1活性来抑制乳腺癌转移。

Paclitaxel inhibits breast cancer metastasis via suppression of Aurora kinase-mediated cofilin-1 activity.

作者信息

Zhang Yue, Wang Yaoyi, Xue Jun

机构信息

Department of Mammography Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei 075000, P.R. China.

Department of Radiology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei 075000, P.R. China.

出版信息

Exp Ther Med. 2018 Feb;15(2):1269-1276. doi: 10.3892/etm.2017.5588. Epub 2017 Dec 1.

DOI:10.3892/etm.2017.5588
PMID:29434713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5776659/
Abstract

The main problem in breast cancer treatment is the recurrence of tumor growth and metastases. Previous studies have suggested that Paclitaxel is widely used to treat various cancers. The present study analyzed the potential signaling pathway of Paclitaxel-inhibited breast cancer metastasis. It was demonstrated that Paclitaxel treatment significantly inhibited growth of breast cancer cell lines including MCF-7 and SKBR3 cells. Results demonstrated that Paclitaxel significantly inhibited breast cancer cell migration and invasion. Results additionally demonstrated that Paclitaxel treatment suppressed Aurora kinase and cofilin-1 activity in breast cancer cells. The potential mechanism indicated that activation of Aurora kinase activity stimulated cofilin-1 activity, which canceled Paclitaxel-inhibited growth and aggressiveness of breast cancer cells. An assay revealed that Paclitaxel treatment significantly inhibited breast cancer growth. Immunohistochemistry demonstrated that Paclitaxel treatment increased apoptosis of tumor cells in tumor tissue. Notably, Aurora kinase and cofilin-1 activity were downregulated by Paclitaxel in tumor tissues. In conclusion, these results indicated that Paclitaxel inhibited breast cancer cell growth and metastasis via suppression of Aurora kinase-mediated cofilin-1 activity, suggesting Paclitaxel may be an efficient anticancer agent for the treatment of this disease.

摘要

乳腺癌治疗中的主要问题是肿瘤生长和转移的复发。先前的研究表明,紫杉醇被广泛用于治疗各种癌症。本研究分析了紫杉醇抑制乳腺癌转移的潜在信号通路。结果表明,紫杉醇处理显著抑制了包括MCF-7和SKBR3细胞在内的乳腺癌细胞系的生长。结果还表明,紫杉醇显著抑制乳腺癌细胞的迁移和侵袭。此外,结果显示紫杉醇处理抑制了乳腺癌细胞中极光激酶和丝切蛋白-1的活性。潜在机制表明,极光激酶活性的激活刺激了丝切蛋白-1的活性,从而抵消了紫杉醇对乳腺癌细胞生长和侵袭性的抑制作用。一项试验表明,紫杉醇处理显著抑制了乳腺癌的生长。免疫组织化学显示,紫杉醇处理增加了肿瘤组织中肿瘤细胞的凋亡。值得注意的是,在肿瘤组织中,紫杉醇下调了极光激酶和丝切蛋白-1的活性。总之,这些结果表明,紫杉醇通过抑制极光激酶介导的丝切蛋白-1活性来抑制乳腺癌细胞的生长和转移,提示紫杉醇可能是治疗该疾病的一种有效抗癌药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947a/5776659/9e5b147cf46d/etm-15-02-1269-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947a/5776659/473f23af1281/etm-15-02-1269-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947a/5776659/da6de0c8ef66/etm-15-02-1269-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947a/5776659/baecf305f444/etm-15-02-1269-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947a/5776659/a3556043d1af/etm-15-02-1269-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947a/5776659/9e5b147cf46d/etm-15-02-1269-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947a/5776659/473f23af1281/etm-15-02-1269-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947a/5776659/da6de0c8ef66/etm-15-02-1269-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947a/5776659/baecf305f444/etm-15-02-1269-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947a/5776659/a3556043d1af/etm-15-02-1269-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947a/5776659/9e5b147cf46d/etm-15-02-1269-g05.jpg

相似文献

1
Paclitaxel inhibits breast cancer metastasis via suppression of Aurora kinase-mediated cofilin-1 activity.紫杉醇通过抑制极光激酶介导的丝切蛋白-1活性来抑制乳腺癌转移。
Exp Ther Med. 2018 Feb;15(2):1269-1276. doi: 10.3892/etm.2017.5588. Epub 2017 Dec 1.
2
The mitotic kinase Aurora-A induces mammary cell migration and breast cancer metastasis by activating the Cofilin-F-actin pathway.有丝分裂激酶 Aurora-A 通过激活丝切蛋白-F-肌动蛋白通路诱导乳腺细胞迁移和乳腺癌转移。
Cancer Res. 2010 Nov 15;70(22):9118-28. doi: 10.1158/0008-5472.CAN-10-1246. Epub 2010 Nov 2.
3
Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple-negative breast cancer.极光激酶 A 通过稳定 FOXM1 增强三阴性乳腺癌对紫杉醇的耐药性。
J Cell Mol Med. 2019 Sep;23(9):6442-6453. doi: 10.1111/jcmm.14538. Epub 2019 Jul 30.
4
Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo.新型 HDAC6 抑制剂 MPT0G211 在人乳腺癌细胞体外和体内的抗转移活性。
Biochim Biophys Acta Mol Cell Res. 2019 Jun;1866(6):992-1003. doi: 10.1016/j.bbamcr.2019.03.003. Epub 2019 Mar 10.
5
Aurora kinase A induces papillary thyroid cancer lymph node metastasis by promoting cofilin-1 activity.极光激酶A通过促进丝切蛋白-1的活性诱导甲状腺乳头状癌淋巴结转移。
Biochem Biophys Res Commun. 2016 Apr 22;473(1):212-218. doi: 10.1016/j.bbrc.2016.03.081. Epub 2016 Mar 19.
6
Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer.极光激酶 B 抑制剂在乳腺癌中的抗肿瘤作用。
Mol Cancer. 2010 Feb 22;9:42. doi: 10.1186/1476-4598-9-42.
7
The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.极光激酶泛抑制剂达纳替尼可诱导人乳腺癌细胞凋亡和自噬,并抑制上皮-间质转化。
Drug Des Devel Ther. 2015 Feb 17;9:1027-62. doi: 10.2147/DDDT.S74412. eCollection 2015.
8
MiR-509-3p Induces Apoptosis and Affects the Chemosensitivity of Cervical Cancer Cells by Targeting the RAC1/PAK1/LIMK1/Cofilin Pathway.miR-509-3p 通过靶向 RAC1/PAK1/LIMK1/肌动蛋白丝解聚因子通路诱导宫颈癌细胞凋亡并影响其化疗敏感性。
Chem Pharm Bull (Tokyo). 2021;69(4):325-332. doi: 10.1248/cpb.c20-00600.
9
ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells.锌指蛋白 217 赋予乳腺癌细胞对紫杉醇诱导的促凋亡信号和 Aurora-A 异常表达的抗性。
Mol Cancer. 2010 Nov 8;9:291. doi: 10.1186/1476-4598-9-291.
10
Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells.基质结合因子 stathmin 启动子驱动的腺病毒介导的 Aurora A shRNA 抑制人乳腺癌细胞的肿瘤生长并增强紫杉醇化疗敏感性。
Cancer Gene Ther. 2012 Apr;19(4):271-81. doi: 10.1038/cgt.2011.89. Epub 2012 Jan 27.

引用本文的文献

1
Extracellular vesicles in triple-negative breast cancer: current updates, challenges and future prospects.三阴性乳腺癌中的细胞外囊泡:当前进展、挑战与未来展望
Front Mol Biosci. 2025 Apr 14;12:1561464. doi: 10.3389/fmolb.2025.1561464. eCollection 2025.
2
A new prognostic model including immune biomarkers, genomic proliferation tumor markers ( and ) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients.一种新的预后模型,包括免疫生物标志物、基因组增殖肿瘤标志物以及临床病理特征,可优化新辅助乳腺癌患者的预后。 (注:原文中“genomic proliferation tumor markers ( and )”表述有误,括号里不应是“and”,这里按正确理解翻译)
Front Oncol. 2023 May 29;13:1182725. doi: 10.3389/fonc.2023.1182725. eCollection 2023.
3

本文引用的文献

1
Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast Cancer.贝伐单抗联合多西他赛或紫杉醇作为HER2阴性转移性乳腺癌的一线治疗方案
Anticancer Res. 2016 Dec;36(12):6431-6438. doi: 10.21873/anticanres.11241.
2
A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE-4).一项随机、适应性的 II/III 期研究,评估了泛 PI3K 抑制剂 Buparlisib 联合紫杉醇治疗 HER2 阳性晚期乳腺癌(BELLE-4)的疗效。
Ann Oncol. 2017 Feb 1;28(2):313-320. doi: 10.1093/annonc/mdw562.
3
Cofilin activation in pancreatic acinar cells plays a pivotal convergent role for mediating CCK-stimulated enzyme secretion and growth.
胰腺腺泡细胞中的丝切蛋白激活在介导胆囊收缩素刺激的酶分泌和生长过程中发挥着关键的汇聚作用。
Front Physiol. 2023 Apr 17;14:1147572. doi: 10.3389/fphys.2023.1147572. eCollection 2023.
4
Construction of Curcumin and Paclitaxel Co-Loaded Lipid Nano Platform and Evaluation of Its Anti-Hepatoma Activity in vitro and Pharmacokinetics in vivo.姜黄素与紫杉醇共载脂质纳米平台的构建及其体内抗肝癌活性和药代动力学评价。
Int J Nanomedicine. 2023 Apr 23;18:2087-2107. doi: 10.2147/IJN.S399289. eCollection 2023.
5
Actin as a Target to Reduce Cell Invasiveness in Initial Stages of Metastasis.肌动蛋白作为降低转移初期细胞侵袭性的靶点。
Ann Biomed Eng. 2021 May;49(5):1342-1352. doi: 10.1007/s10439-020-02679-7. Epub 2020 Nov 3.
6
Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy.载紫杉醇巨噬细胞膜伪装白蛋白纳米粒用于靶向癌症治疗。
Int J Nanomedicine. 2020 Mar 19;15:1915-1928. doi: 10.2147/IJN.S244849. eCollection 2020.
7
Resveratrol Enhances Apoptotic and Oxidant Effects of Paclitaxel through TRPM2 Channel Activation in DBTRG Glioblastoma Cells.白藜芦醇通过激活 DBTRG 神经胶质瘤细胞中的 TRPM2 通道增强紫杉醇的凋亡和氧化作用。
Oxid Med Cell Longev. 2019 Mar 7;2019:4619865. doi: 10.1155/2019/4619865. eCollection 2019.
Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
pH响应性配体修饰的纳米载体共递送紫杉醇和DNA用于乳腺癌治疗时的抗肿瘤效果
Biomed Pharmacother. 2016 Oct;83:1428-1435. doi: 10.1016/j.biopha.2016.08.061. Epub 2016 Sep 1.
4
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment.紫杉醇与MG1溶瘤病毒联合使用作为乳腺癌治疗的成功策略。
Breast Cancer Res. 2016 Aug 8;18(1):83. doi: 10.1186/s13058-016-0744-y.
5
Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study.多中心全国观察性研究:紫杉醇联合贝伐珠单抗或紫杉醇作为 HER2 阴性转移性乳腺癌一线治疗。
Ann Oncol. 2016 Sep;27(9):1725-32. doi: 10.1093/annonc/mdw260. Epub 2016 Jul 19.
6
Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer.极光A选择性激酶抑制剂阿利西替尼对结直肠癌临床前模型的抗肿瘤活性。
Oncotarget. 2016 Aug 2;7(31):50290-50301. doi: 10.18632/oncotarget.10366.
7
Metaplastic carcinoma of breast: A case series of seven patients from a tertiary care center and review of literature.乳腺化生性癌:来自一家三级医疗中心的7例病例系列报道及文献复习
Gulf J Oncolog. 2016 May;1(21):74-6.
8
[Efficacy and Safety of Neoadjuvant Chemotherapy Containing Nanoparticle Albumin-Bound Paclitaxel (NabPTX) in Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer].含纳米白蛋白结合型紫杉醇(NabPTX)的新辅助化疗在可手术的人表皮生长因子受体2阳性乳腺癌中的疗效与安全性
Gan To Kagaku Ryoho. 2016 May;43(5):579-82.
9
Acinic cell carcinoma of breast: morphologic and immunohistochemical review of a rare breast cancer subtype.乳腺腺泡细胞癌:一种罕见乳腺癌亚型的形态学和免疫组化回顾
Hum Pathol. 2016 May;51:16-24. doi: 10.1016/j.humpath.2015.12.014. Epub 2016 Jan 7.
10
Aurora kinase A induces papillary thyroid cancer lymph node metastasis by promoting cofilin-1 activity.极光激酶A通过促进丝切蛋白-1的活性诱导甲状腺乳头状癌淋巴结转移。
Biochem Biophys Res Commun. 2016 Apr 22;473(1):212-218. doi: 10.1016/j.bbrc.2016.03.081. Epub 2016 Mar 19.